-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Mn3nIF2QDJyxu+fWzE4nZyL64L/MetvUIRb+RBw8ow/NvtmFvQOliAN1qU7qX0Bt 3duPNjUMj6gX9/a6iIjxTQ== 0001079973-07-000106.txt : 20070214 0001079973-07-000106.hdr.sgml : 20070214 20070214173645 ACCESSION NUMBER: 0001079973-07-000106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070212 FILED AS OF DATE: 20070214 DATE AS OF CHANGE: 20070214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROVARONE DENNIS CENTRAL INDEX KEY: 0001053769 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21019 FILM NUMBER: 07623579 BUSINESS ADDRESS: BUSINESS PHONE: 3034664092 MAIL ADDRESS: STREET 1: C/O INNOVATIVE MEDICAL SERVICES STREET 2: 1725 GILLESPIE WAY CITY: EL CAJON STATE: CA ZIP: 92020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PURE BIOSCIENCE CENTRAL INDEX KEY: 0001006028 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 330530289 STATE OF INCORPORATION: CA FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 1725 GILLESPIE WAY STREET 2: STE H CITY: EL CAJON STATE: CA ZIP: 92020 BUSINESS PHONE: 6195968600 MAIL ADDRESS: STREET 1: 1725 GILLESPIE WAY STREET 2: SUITE H CITY: EL CAJON STATE: CA ZIP: 92020 FORMER COMPANY: FORMER CONFORMED NAME: PURE BIOSCIENCES DATE OF NAME CHANGE: 20031029 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE MEDICAL SERVICES DATE OF NAME CHANGE: 19960122 4 1 primary_doc.xml PRIMARY DOCUMENT X0202 4 2007-02-12 0 0001006028 PURE BIOSCIENCE PURE 0001053769 BROVARONE DENNIS C/O PURE BIOSCIENCE 1725 GILLESPIE WAY EL CAJON CA 92020 1 0 0 0 Common Stock 2007-02-12 4 S 0 1500 2.4 D 202181 D Common Stock 2007-02-12 4 S 0 1500 2.41 D 202181 D Common Stock 4080 I As custodian for minor children The sale was made pursuant to a plan adopted February 8, 2007 intended to comply with Rule 10b5-1 No other changes were made to derivative securities /s/ Dennis Brovarone 2007-02-14 -----END PRIVACY-ENHANCED MESSAGE-----